Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + mFOLFOX6 in metastatic colorectal cancer
NCT00865709Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of sorafenib in metastatic colorectal cancer (mCRC), sponsored by Bayer. Started Mar 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00865709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00865709.